A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)

Kumar, Princy N; Salvato, Patricia; LaMarca, Anthony; DeJesus, Edwin; Patel, Parul; McClernon, Daniel; Florance, Allison; Shaefer, Mark S

doi:10.1186/1742-6405-6-3

AIDS Research and Therapy

Article metrics
Last updated: Sat, 20 Apr 2024 8:58:06 Z

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)

Access & Citations

8060

Article Accesses
0

Web of Science
16

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1742-6405

Contact us

Submission enquiries: journalsubmissions@springernature.com